ScoreWhy is Harbin Medisan Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of -9.52% and Operating profit at -324.14% over the last 5 years
3
With a fall in Operating Profit of -980.15%, the company declared Very Negative results in Sep 25
- ROCE(HY) Lowest at -9.43%
- DEBT-EQUITY RATIO (HY) Highest at 20.72 %
- RAW MATERIAL COST(Y) Grown by 6.31% (YoY)
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 17.60%, its profits have fallen by -186.9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Harbin Medisan Pharmaceutical Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Harbin Medisan Pharmaceutical Co., Ltd.
12.78%
0.42
58.25%
China Shanghai Composite
15.17%
1.02
14.86%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-9.52%
EBIT Growth (5y)
-324.14%
EBIT to Interest (avg)
-3.11
Debt to EBITDA (avg)
0.58
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
0.36
Tax Ratio
9.59%
Dividend Payout Ratio
107.18%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
6.10%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.01
EV to EBIT
-59.62
EV to EBITDA
76.34
EV to Capital Employed
1.85
EV to Sales
4.38
PEG Ratio
NA
Dividend Yield
1.57%
ROCE (Latest)
-3.10%
ROE (Latest)
-2.27%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 132.62 MM
-41What is not working for the Company
ROCE(HY)
Lowest at -9.43%
DEBT-EQUITY RATIO
(HY)
Highest at 20.72 %
RAW MATERIAL COST(Y)
Grown by 6.31% (YoY
CASH AND EQV(HY)
Lowest at CNY 1,321.63 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.16 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.76 times
NET SALES(Q)
Lowest at CNY 167.53 MM
OPERATING PROFIT(Q)
Lowest at CNY -127.55 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -76.13 %
PRE-TAX PROFIT(Q)
Lowest at CNY -127.66 MM
NET PROFIT(Q)
Lowest at CNY -118.46 MM
EPS(Q)
Lowest at CNY -0.37
Here's what is working for Harbin Medisan Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 132.62 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Here's what is not working for Harbin Medisan Pharmaceutical Co., Ltd.
Net Sales
At CNY 167.53 MM has Fallen at -34.25%
over average net sales of the previous four periods of CNY 254.79 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Pre-Tax Profit
At CNY -127.66 MM has Fallen at -611.97%
over average net sales of the previous four periods of CNY -17.93 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -118.46 MM has Fallen at -1,020.02%
over average net sales of the previous four periods of CNY -10.58 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Debt-Equity Ratio
Highest at 20.72 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Lowest at CNY 167.53 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Operating Profit
Lowest at CNY -127.55 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -76.13 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY -127.66 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY -118.46 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY -0.37
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Cash and Eqv
Lowest at CNY 1,321.63 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 2.16 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 6.76 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 6.31% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
